메뉴 건너뛰기




Volumn 19, Issue 2, 2003, Pages 90-97

Targeted therapies for the treatment of leukemia

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ALPHA INTERFERON; ARSENIC TRIOXIDE; CYTARABINE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; DEXAMETHASONE; DIPHENHYDRAMINE; ERYTHROMYCIN; FLUCONAZOLE; GEMTUZUMAB OZOGAMICIN; HYDROCORTISONE; IMATINIB; ITRACONAZOLE; KETOCONAZOLE; PARACETAMOL; PETHIDINE; RETINOIC ACID; STEROID; TRISONEX; VALACICLOVIR; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CANCER ANTIBODY; GEMTUZUMAB; MONOCLONAL ANTIBODY; ORGANOARSENIC DERIVATIVE; OXIDE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

EID: 0038500691     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-2081(03)00005-6     Document Type: Article
Times cited : (2)

References (26)
  • 2
    • 0034327634 scopus 로고    scopus 로고
    • NCCN Proceedings: New developments in the treatment of acute myeloid leukemia
    • Radich J., Sievers E. NCCN Proceedings New developments in the treatment of acute myeloid leukemia. Oncology. 14:2000;125-131
    • (2000) Oncology , vol.14 , pp. 125-131
    • Radich, J.1    Sievers, E.2
  • 3
    • 0036667933 scopus 로고    scopus 로고
    • Gemtuzumab ozogamicin (CMA-676, Mylotarg) for the treatment of CD33+ acute myeloid leukemia
    • Voutsadakis I.A. Gemtuzumab ozogamicin (CMA-676, Mylotarg) for the treatment of CD33+ acute myeloid leukemia. Anticancer Drugs. 13:2002;685-692
    • (2002) Anticancer Drugs , vol.13 , pp. 685-692
    • Voutsadakis, I.A.1
  • 6
    • 0342368618 scopus 로고    scopus 로고
    • Current issues in the management of acute promyelocytic leukemia
    • Slack J.L., Rusiniak M.E. Current issues in the management of acute promyelocytic leukemia. Ann Hematol. 79:2000;227-238
    • (2000) Ann Hematol , vol.79 , pp. 227-238
    • Slack, J.L.1    Rusiniak, M.E.2
  • 8
    • 0030923479 scopus 로고    scopus 로고
    • All-trans-retinoic acid in acute promyelocytic leukemia
    • Tallman M.S., Anderson J.W., Schiffer C.A., et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med. 337:1997;1021-1028
    • (1997) N Engl J Med , vol.337 , pp. 1021-1028
    • Tallman, M.S.1    Anderson, J.W.2    Schiffer, C.A.3
  • 9
    • 0028008950 scopus 로고
    • All trans retinoic acid for acute promyelocytic leukemia
    • Frankel S.R., Eardly A., Heller G., et al. All trans retinoic acid for acute promyelocytic leukemia. Ann Intern Med. 120:1994;278-286
    • (1994) Ann Intern Med , vol.120 , pp. 278-286
    • Frankel, S.R.1    Eardly, A.2    Heller, G.3
  • 10
    • 0035041127 scopus 로고    scopus 로고
    • Clinical trials of arsenic trioxide in hematologic and solid tumors: Overview of the national cancer institute cooperative research and development studies
    • Murgo A.J. Clinical trials of arsenic trioxide in hematologic and solid tumors Overview of the national cancer institute cooperative research and development studies. Oncologist. 6:(suppl 2):2001;22-28
    • (2001) Oncologist , vol.6 , Issue.SUPPL. 2 , pp. 22-28
    • Murgo, A.J.1
  • 11
    • 12244278447 scopus 로고    scopus 로고
    • Arsenic trioxide in patients with myelodysplastic syndromes: Preliminary findings an a phase II clinical study
    • (abstr 1072)
    • Singer J., Douer D., Mason J., et al. Arsenic trioxide in patients with myelodysplastic syndromes Preliminary findings an a phase II clinical study. 7th Congress of European Haematology Association. 2002;. (abstr 1072)
    • (2002) 7th Congress of European Haematology Association
    • Singer, J.1    Douer, D.2    Mason, J.3
  • 13
    • 0035884639 scopus 로고    scopus 로고
    • United States Multicenter Study of arsenic trioxide in relapsed acute promyelocytic leukemia
    • Soignet S.L., Frankel S.R., Dover D., et al. United States Multicenter Study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol. 19:2001;3852-3860
    • (2001) J Clin Oncol , vol.19 , pp. 3852-3860
    • Soignet, S.L.1    Frankel, S.R.2    Dover, D.3
  • 14
    • 0001913027 scopus 로고    scopus 로고
    • Chronic myeloid leukemia
    • M.D. Abelhoff, J.O. Armitage, A.S. Lichter, & J.E. Niederhuber. Philadelphia, PA: Churchill Livingstone
    • Yong A., Goldman J.M. Chronic myeloid leukemia. Abelhoff M.D., Armitage J.O., Lichter A.S., Niederhuber J.E. Clinical Oncology. ed 2. 2000;2579-2596 Churchill Livingstone, Philadelphia, PA
    • (2000) Clinical Oncology Ed 2. , pp. 2579-2596
    • Yong, A.1    Goldman, J.M.2
  • 15
    • 0033614446 scopus 로고    scopus 로고
    • Chronic myeloid leukemia
    • Sawyers C.L. Chronic myeloid leukemia. N Engl J Med. 340:1999;1330-1340
    • (1999) N Engl J Med , vol.340 , pp. 1330-1340
    • Sawyers, C.L.1
  • 16
    • 0035844320 scopus 로고    scopus 로고
    • Gleevec (STI-571) for chronic myeloid leukemia. The Medical Letter. 43:2001;49-50
    • (2001) The Medical Letter , vol.43 , pp. 49-50
  • 18
    • 10744233716 scopus 로고    scopus 로고
    • Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
    • O'Brien S.G., Guilhot F., Larson R.A., et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 348:2003;994-1004
    • (2003) N Engl J Med , vol.348 , pp. 994-1004
    • O'Brien, S.G.1    Guilhot, F.2    Larson, R.A.3
  • 19
    • 2342612477 scopus 로고    scopus 로고
    • Campath product monograph. Berlex Oncology. 2002
    • (2002) Berlex Oncology
  • 20
    • 0035895032 scopus 로고    scopus 로고
    • Alemtuzumab. Am J Health Syst Phar. 58:2001;2372-2373
    • (2001) Am J Health Syst Phar , vol.58 , pp. 2372-2373
  • 21
    • 0031027623 scopus 로고    scopus 로고
    • Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukemia
    • Bowen A.L., Zomas A., Emmett E., et al. Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukemia. Br J Haematol. 96:1997;617-619
    • (1997) Br J Haematol , vol.96 , pp. 617-619
    • Bowen, A.L.1    Zomas, A.2    Emmett, E.3
  • 22
    • 0036683449 scopus 로고    scopus 로고
    • Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-H) as a first line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
    • Lundin J., Kimby E., Bjorkholm M., et al. Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-H) as a first line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL). Blood. 100:2002;768-773
    • (2002) Blood , vol.100 , pp. 768-773
    • Lundin, J.1    Kimby, E.2    Bjorkholm, M.3
  • 23
    • 0348116722 scopus 로고    scopus 로고
    • Guidelines for preventing infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 6:2000;667-672
    • (2000) Biol Blood Marrow Transplant , vol.6 , pp. 667-672
  • 24
    • 0034307366 scopus 로고    scopus 로고
    • In vivo CAMPATH - 1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
    • Kottaridis P.D., Milligan D.W., Chopra R., et al. In vivo CAMPATH - 1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood. 96:2000;2419-2425
    • (2000) Blood , vol.96 , pp. 2419-2425
    • Kottaridis, P.D.1    Milligan, D.W.2    Chopra, R.3
  • 25
    • 0031757274 scopus 로고    scopus 로고
    • CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: A phase II multicenter study
    • Lundin J., Osterborg A., Brittinger G., et al. CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas A phase II multicenter study. J Clin Oncol. 16:1998;3257-3263
    • (1998) J Clin Oncol , vol.16 , pp. 3257-3263
    • Lundin, J.1    Osterborg, A.2    Brittinger, G.3
  • 26
    • 0034786378 scopus 로고    scopus 로고
    • The effect of treatment with campath-1H in patients with autoimmune cytopenias
    • Willis F., Marsh J.C.W., Bevan D.H., et al. The effect of treatment with campath-1H in patients with autoimmune cytopenias. Br J Haematol. 114:2001;891-898
    • (2001) Br J Haematol , vol.114 , pp. 891-898
    • Willis, F.1    Marsh, J.C.W.2    Bevan, D.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.